Stocktoria
Healthcare Triangle, Inc. HCTI
Healthcare Triangle, Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $13.9M | $11.7M | — | $33.2M | $45.9M | $35.3M | $31.3M |
| R&D expense | $536,000 | $429,000 | — | $799,000 | $6.0M | $5.3M | $1.7M |
| SG&A expense | — | — | — | — | $0 | $0 | — |
| Operating income | -$9.8M | -$4.8M | — | -$7.7M | -$10.4M | -$5.4M | $1.2M |
| Interest expense | $567,000 | — | — | — | $212,000 | $567,000 | $78,646 |
| Income tax | — | $12,000 | — | $35,000 | $63,000 | $24,000 | $257,381 |
| Net income | -$9.5M | -$6.0M | — | -$8.7M | -$9.6M | -$5.9M | $2.4M |
| EPS (diluted) | $-152.30 | $-16909.30 | — | $-2.08 | $-2.63 | $-0.20 | $0.08 |
| Operating cash flow | -$16.5M | -$1.1M | — | -$2.2M | -$2.6M | -$7.1M | -$734,675 |
| Free cash flow | -$16.5M | — | — | -$2.2M | -$2.6M | — | — |
| Cash & equivalents | $7.6M | $20,000 | $29,000 | $1.2M | $1.3M | $1.8M | $1.4M |
| Total assets | $22.7M | $2.0M | $6.0M | $6.9M | $20.8M | $24.6M | $11.1M |
| Total liabilities | $12.8M | $7.1M | $6.7M | $8.2M | $8.4M | $8.5M | $6.8M |
| Shareholders' equity | $9.9M | -$5.1M | -$646,000 | -$1.4M | $12.4M | $16.1M | $4.3M |
Growth · year-over-year · Revenue CAGR -15%
| Metric | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue growth | +18.8% | — | — | -27.6% | +30.1% | +12.5% | — |
| Net income growth | — | — | — | — | — | -352.8% | — |
| EPS growth | — | — | — | — | — | -340.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.